Oxytocin levels predict HPA-axis response to selective serotonin reuptake inhibitors (SSRIs) in patients with major depression

被引:0
|
作者
Keating, C. [1 ]
Dawood, T. [2 ]
Lambert, G.
Barton, D.
Kulkarni, J. [1 ]
Tilbrook, A.
机构
[1] Monash Univ, Melbourne, Vic 3004, Australia
[2] Baker IDI, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [41] Depression and the Use of Selective Serotonin Reuptake Inhibitors in Patients with Acute Intracerebral Hemorrhage
    Syed, Maryam J.
    Farooq, Salman
    Siddiqui, Sarwar
    Awan, Safia
    Wasay, Mohammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (10)
  • [42] Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients
    Worthington, JJ
    Kinrys, G
    Wygant, LE
    Pollack, MH
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (01) : 9 - 11
  • [43] Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients
    Montgomery, SA
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 : S49 - S54
  • [44] POLYGENIC SCORE FOR CARDIOMETABOLIC AND PSYCHIATRIC PHENOTYPES PREDICT RESPONSE TO TREATMENT WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN MAJOR DEPRESSIVE DISORDER
    Baune, Bernhard
    Amare, Azmeraw
    Schubert, K. Oliver
    Biernacka, Joanna
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S512 - S513
  • [45] Polymorphism of the serotonin transporter promoter may predict the response to selective serotonin reuptake inhibitors in bulimia nervosa
    Giaquinto, K.
    Capasso, A.
    Monteleone, P.
    Maj, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S226 - S226
  • [46] Association of Serum Biomarker Levels and BDNF Gene Polymorphism with Response to Selective Serotonin Reuptake Inhibitors in Indian Patients with Major Depressive Disorder
    Ramesh, Varsha
    Venkatesan, Vettriselvi
    Chellathai, Darling
    Silamban, Santhi
    NEUROPSYCHOBIOLOGY, 2021, 80 (03) : 201 - 213
  • [47] Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
    Srivastava, Ankit
    Singh, Priyanka
    Gupta, Hitesh
    Kaur, Harpreet
    Kanojia, Neha
    Guin, Debleena
    Sood, Mamta
    Chadda, Rakesh Kumar
    Yadav, Jyoti
    Vohora, Divya
    Saso, Luciano
    Kukreti, Ritushree
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (08)
  • [48] Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): A systematic review of randomized clinical trials
    De Crescenzo, Franco
    Perelli, Federica
    Armando, Marco
    Vicari, Stefano
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 152 : 39 - 44
  • [49] Effect of Selective Serotonin Reuptake Inhibitors and Immunomodulator on Cytokines Levels: An Alternative Therapy for Patients with Major Depressive Disorder
    Eugenia Hernandez, Maria
    Mendieta, Danelia
    Perez-Tapia, Mayra
    Bojalil, Rafael
    Estrada-Garcia, Iris
    Estrada-Parra, Sergio
    Pavon, Lenin
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [50] Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews
    Darab, Mohsen Ghaffari
    Hedayati, Arvin
    Khorasani, Elahe
    Bayati, Mohsen
    Keshavarz, Khosro
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2020, 24 (04) : 357 - 370